N30 Pharma pulls in $30 mln

Boulder, Colorado-based N30 Pharma, which focuses on developing therapies for cystic fibrosis, has received $30 million in financing. The investors included Wellington Management, RA Capital Management, Jennison Associates (on behalf of certain clients), Rock Springs Capital Management, Sabby Management and Deerfield Management Company. Cowen & Co. served as a placement agent.

North AmericaUSBriefs